Arvinas, Inc.
ARVN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001655759
No open-market purchases or sales by Arvinas, Inc. insiders were filed in the last 90 days; 201 institutions reported holding it in 13F filings for Q2 2026, worth $468.7M in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Arvinas, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Arvinas, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Norwalk Leslie V | Director | 41,572 | Jun 26, 2026 | 1 |
| Cunningham Everett | Director | 41,572 | Jun 26, 2026 | 1 |
| Bain Linda | Director | 41,572 | Jun 26, 2026 | 1 |
| Smaldone Alsup Laurie | Director | 41,572 | Jun 26, 2026 | 1 |
| Morrison Briggs | Director | 111,548 | Jun 26, 2026 | 2 |
| Kennedy Edward Moore Jr. | Director | 54,957 | Jun 26, 2026 | 1 |
| Saik Andrew | Chief Financial Officer | 187,432 | Jun 24, 2026 | 4 |
| Cacace Angela M | Chief Scientific Officer | 180,390 | Jun 18, 2026 | 5 |
| Teel Randy | President and CEO | 285,009 | May 22, 2026 | 5 |
| Berkowitz Noah | Chief Medical Officer | 191,395 | May 13, 2026 | 4 |
| Loomis David K | VP, Chief Accounting Officer | 40,193 | May 13, 2026 | 5 |
| Houston John G | Director | 1,122,183 | Mar 2, 2026 | 1 |
| Agarwal Sunil | Director | 30,166 | Jun 30, 2025 | 0 |
| Young John D | Director | 26,045 | Jun 27, 2025 | 0 |
| Taylor Ian | President, R&D | 159,121 | Feb 25, 2025 | 0 |
| Cassidy Sean A | Chief Financial Officer | 181,916 | Feb 27, 2024 | 0 |
| Peck Ronald | Chief Medical Officer | 67,516 | Feb 27, 2024 | 0 |
| Dixon Wendy L | Director | 9,121 | Jun 20, 2023 | 0 |
| Shannon Timothy M | Director | 1,653,128Indirect | Jun 21, 2022 | 0 |
| Ratcliffe Liam | Director | 185,686Indirect | Jun 21, 2022 | 0 |
| Margus Bradley Albert | Director | 2,000Indirect | Jun 21, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 9, 2021 (view filing) | Nov 5 | 4 days | Ratcliffe LiamDirector | SSale | −24.9K | $91.30 | −$2.28M | −100.0%0 after | 6 lots |
| Nov 9, 2021 (view filing) | Nov 5-9 | 4 days | Ratcliffe LiamDirector | SSale | −147.2K | $93.31 | −$13.7M | −17.9%675.7K after | 12 lots |
| Nov 3, 2021 (view filing) | Nov 1 | 2 days | Houston John GPresident and CEO | SSale | −40.0K | $88.14 | −$3.53M | −4.6%832.3K after | 3 lots |
| Sep 27, 2021 (view filing) | Sep 3-7 | 24 daysLate | Shannon Timothy MDirector | SSale | −68.8K | $87.42 | −$6.01M | −4.0%1.65M after | 6 lots |
| Sep 27, 2021 (view filing) | Aug 31-Sep 2 | 27 daysLate | Shannon Timothy MDirector | SSale | −190.6K | $86.26 | −$16.4M | −10.0%1.72M after | 8 lots |
| Sep 27, 2021 (view filing) | Aug 26-30 | 32 daysLate | Shannon Timothy MDirector | SSale | −115.6K | $85.72 | −$9.91M | −5.7%1.91M after | 7 lots |
| Sep 27, 2021 (view filing) | Aug 23-25 | 35 daysLate | Shannon Timothy MDirector | SSale | −25.1K | $85.95 | −$2.15M | −1.2%2.03M after | 4 lots |
| Aug 27, 2021 (view filing) | Aug 25-26 | 2 days | Margus Bradley AlbertDirector | SSale | −29.9K | $85.01 | −$2.55M | −93.7%2.00K after | 2 lots |
| Aug 18, 2021 (view filing) | Aug 16 | 2 days | Taylor IanChief Scientific Officer | SSale | −20.0K | $87.30 | −$1.75M | −20.3%78.6K after | 3 lots |
| Aug 16, 2021 (view filing) | Aug 12 | 4 days | Peck RonaldChief Medical Officer | SSale | −1.36K | $90.54 | −$123.4K | −20.1%5.40K after | |
| Aug 13, 2021 (view filing) | Aug 11-13 | 2 days | Margus Bradley AlbertDirector | SSale | −10.8K | $90.03 | −$974.8K | −25.3%31.9K after | 2 lots |
| Aug 4, 2021 (view filing) | Aug 2 | 2 days | Houston John GPresident and CEO | SSale | −45.9K | $97.83 | −$4.49M | −5.3%827.6K after | 5 lots |
| Jul 30, 2021 (view filing) | Jul 28 | 2 days | Cassidy Sean AChief Financial Officer | SSale | −17.2K | $100.00 | −$1.72M | −9.8%158.2K after | |
| Jul 2, 2021 (view filing) | Jun 30 | 2 days | Peck RonaldChief Medical Officer | SSale | −20.0K | $76.69 | −$1.53M | −87.9%2.75K after |